DSM’s new DHA oil for maternal and infant nutrition offers higher dose in smaller product format
The ingredient contains a minimum of 550 mg/g natural triglyceride DHA (docosahexaenoic acid), allowing manufacturers to achieve equivalent dosages of DHA in smaller product formats.
Photo © iStockphoto.com/Rinelle
Royal DSM (Heerlan, The Netherlands) has launched its new, higher potency life’sDHA SF55-O200DS oil for maternal and early life nutrition solutions. The ingredient contains a minimum of 550 mg/g natural triglyceride DHA (docosahexaenoic acid), allowing manufacturers to achieve equivalent dosages of DHA in smaller product formats.
DMS’s life’sDHA SF55-O200DS oil is produced from Schizochytrium algae, offering a sustainable, plant-based alternative to fish oil, and is contaminant-free, kosher, and halal. The product, which can be consumed in a convenient single dose is both aimed at women who are planning to conceive, are pregnant, breastfeeding, or non-breastfeeding post-natal mothers, as well as infants.
“Convenience, quality, and safety are key drivers of consumer purchasing in the maternal and early life nutrition markets, with mothers and expectant moms looking for easy-to-swallow dietary supplements and safe infant nutrition products made with trusted, science-backed ingredients,” said Brent MacDonald, director global marketing and business development, Nutritional Lipids at DSM, in a press release. “We carefully formulated life’sDHA SF55-O200DS to help manufacturers develop high-quality, reliable DHA solutions that will give pregnant women and moms peace of mind and that will shape healthier futures worldwide.”
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
